ArticleNPJ breast cancer2025

Personalized mutation tracking in circulating-tumor DNA predicts recurrence in patients with high-risk early breast cancer.

Sao Trung Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.